Physician use of beta-adrenergic blocking therapy: a changing perspective
- 31 August 1995
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 26 (2), 547-552
- https://doi.org/10.1016/0735-1097(95)80035-f
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Antiatherogenic effects of β-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerationsAmerican Heart Journal, 1994
- Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmiasAmerican Heart Journal, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Electrophysiologic and antiarrhythmic actions of nadolol: Acute ischemia in the presence of previous myocardial infarctionAmerican Heart Journal, 1988
- Randomized Clinical Trial of Atenolol in Patients with Alcohol WithdrawalNew England Journal of Medicine, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blockerAmerican Heart Journal, 1979
- Metoprolol for Essential TremorNew England Journal of Medicine, 1979